CN110934815A - Anti-saccharification mask containing mesenchymal stem cell culture supernatant and preparation method thereof - Google Patents

Anti-saccharification mask containing mesenchymal stem cell culture supernatant and preparation method thereof Download PDF

Info

Publication number
CN110934815A
CN110934815A CN201911342835.4A CN201911342835A CN110934815A CN 110934815 A CN110934815 A CN 110934815A CN 201911342835 A CN201911342835 A CN 201911342835A CN 110934815 A CN110934815 A CN 110934815A
Authority
CN
China
Prior art keywords
mesenchymal stem
cell culture
culture supernatant
stem cell
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201911342835.4A
Other languages
Chinese (zh)
Inventor
李慧芳
王悦朋
孙爽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shengshi Biotechnology Co Ltd
Original Assignee
Shengshi Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shengshi Biotechnology Co Ltd filed Critical Shengshi Biotechnology Co Ltd
Priority to CN201911342835.4A priority Critical patent/CN110934815A/en
Publication of CN110934815A publication Critical patent/CN110934815A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/347Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4986Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/731Cellulose; Quaternized cellulose derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728Fungi, e.g. yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/987Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/805Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)

Abstract

The invention discloses a preparation method of an anti-saccharification mask containing mesenchymal stem cell culture supernatant, which comprises the following steps: preparing a mesenchymal stem cell culture supernatant, preparing a base solution, adding the mesenchymal stem cell culture supernatant obtained in the step (1) into the base solution obtained in the step (2) after a high-speed mixer cools to room temperature, and carrying out high-speed mixing and stirring to obtain the anti-saccharification mask containing the mesenchymal stem cell culture supernatant, wherein the mask solution comprises: consists of 0.1 to 5 percent of mesenchymal stem cell culture supernatant and 95 to 99.9 percent of base solution by mass ratio. According to the invention, the mesenchymal stem cell culture supernatant is combined with the anti-glycation functional components, so that the skin improvement effect is better than that of the anti-glycation functional components such as the mesenchymal stem cell culture supernatant or resveratrol, carnosine, lipoic acid and the like, the skin elasticity is increased, the color and the glossiness of the skin are improved, the barrier function of the skin is improved, the water is locked and the moisture is preserved, the wrinkles and the skin texture are improved, and the skin problem is solved from the internal cell level.

Description

Anti-saccharification mask containing mesenchymal stem cell culture supernatant and preparation method thereof
Technical Field
The invention relates to the technical field of cosmetics, in particular to an anti-saccharification mask containing mesenchymal stem cell culture supernatant and a preparation method thereof.
Background
Along with the social development and the improvement of living standard of people, people pay more attention to the self care and skin care, especially women, but the cosmetics in the market at present have various varieties, great effect difference and difficult discrimination of consumers. Some fine chemical skin care products are added with substances harmful to human skin, such as lead, mercury and the like, in order to pursue whitening effect, so that the problems of skin inflammation and infection are caused. On the other hand, the existing cosmetic products contain less bioactive substances, cannot fundamentally improve the growth state and metabolism of epidermal cells, and have limited repair effect on skin.
With the increase of human age, the activity of cells is weakened, and the metabolism function in vivo is deteriorated, thereby causing various phenomena such as aging and saccharification. Glycation is mainly due to the fact that excessive sugar ingested by a human body can be combined with protein structures in the body,product produced by birthThe aging substances, namely saccharification end products (AGEs), can intervene in human metabolism, cross-link protein structures, make skin difficult to repair, cause the skin color to be yellow and dark, loose, increase wrinkles and generate aging signs. Saccharification can also result in large oil output, large pores, acne, and rough and unsmooth skin. Anti-glycation cosmetic mainly containing resveratrol, carnosine, thioctic acid, etcHas antioxidant and whitening effects, and can improve skin saccharification.
The mesenchymal stem cells exist in various tissues and organs of an organism, are a group of pluripotent stem cells with multidirectional differentiation potential, comprise mesenchymal stem cells from bone marrow, umbilical cord, fat and the like, and have the characteristics of convenient material acquisition, easy amplification, low immunogenicity and the like. The existing research shows that the mesenchymal stem cells have the functions of tissue repair, immune function regulation and the like, and can secrete various growth factors, including epidermal growth factor EGF, basic fibroblast growth factor bFGF and the like. The mesenchymal stem cell culture supernatant contains the growth factor, can remarkably promote the proliferation of dermal fibroblasts and the generation of collagen and elastin, and has anti-aging potential in the field of cosmetics. At present, the method for culturing the mesenchymal stem cells and obtaining the culture supernatant of the mesenchymal stem cells still needs to be improved so as to meet the requirement of mass stable production.
The inventor finds that the anti-saccharification product provided by the prior art does not have a high-efficiency anti-saccharification facial mask containing mesenchymal stem cell culture supernatant. Based on this, the invention provides an anti-glycation mask which is superior to the existing anti-glycation components, has a good moisturizing effect, increases the skin elasticity, improves the skin color and glossiness, can obviously reduce fine lines, enables the skin to be fine and smooth, improves the skin inflammation and the like, and has an effect superior to a mask which is only added with anti-glycation components such as adipose mesenchymal stem cell culture supernatant or resveratrol, carnosine, lipoic acid and the like, thereby completing the invention.
Disclosure of Invention
The invention aims to provide an anti-saccharification mask containing mesenchymal stem cell culture supernatant and a preparation method thereof, so as to solve the problems in the background technology.
In order to achieve the purpose, the invention provides the following technical scheme: a preparation method of an anti-saccharification mask containing mesenchymal stem cell culture supernatant comprises the following steps:
(1) preparing a mesenchymal stem cell culture supernatant: pretreating a cell culture container by using fibronectin, sucking away the fibronectin after pretreatment, then paving the domesticated P1-P30 generation mesenchymal stem cells in the culture container, changing the liquid on the next day, collecting culture supernatant on the third day, and filtering the culture supernatant with a 0.22 mu m filter membrane for later use;
(2) preparing a base solution: heating a component A comprising 1-10% of glycerol, 1-4% of butanediol, 1-5% of 1, 2-pentanediol, 0.1-5% of dipropylene glycol, 0.5-5% of diglycerol, 0.5-4% of sucrose, 0.5-3% of sodium PCA, 0.01-1% of PEG-60 hydrogenated castor oil, 0.1-0.3% of xanthan gum and the balance of water to 80-85 ℃, carrying out high-speed mixing stirring, adding a component B comprising 0.1-0.5% of citric acid, 0.1-0.5% of sodium citrate and the balance of water when the high-speed mixer is cooled to below 40 ℃, carrying out high-speed mixing stirring, and then adding 0.1-0.5% of phenoxyethanol, 0.1-1% of betaine, 0.1-1% of hydroxyethyl cellulose, 0.0001-1% of carnosine, 0.0001-0.1% of lipoic acid, 0.0001-1% of resveratrol, 0.001-1% of grape seed extract, 0.001-1% of wild soybean extract, 0.001-1% of centella asiatica extract, 0.01-1% of hydrolyzed silk, 0.0001-1% of oligopeptide-5, 0.001-1% of hydrolyzed yeast extract, 0.001-0.3% of daily essence and the balance of water;
(3) and (3) after the high-speed mixer is cooled to room temperature, adding the mesenchymal stem cell culture supernatant in the step (1) into the base solution in the step (2), and carrying out high-speed mixing and stirring.
Preferably, the domestication method of the mesenchymal stem cells is serum-free culture medium culture.
Preferably, the tissue containing mesenchymal stem cells is derived from umbilical cord, placenta, fat, bone marrow or dental pulp of a healthy subject.
Preferably, the mesenchymal stem cells are extracted by washing the blood cells with phosphate buffer solution and cutting into pieces of about 1mm3Adding 2mL of 1mg/mL collagenase I digestive juice into the fine tissue blocks, transferring the mixture into a 15mL centrifuge tube, carrying out shaking digestion on a constant temperature shaking table at 37 ℃ for 30min, and adding the equal volume mesenchymal stem cell complete culture medium after no large tissue blocks existFinal (a Chinese character of 'gan')Stopping digestion, centrifuging at 1000rpm for 8min to settle cells, discardingRemoving supernatant and suspended adipose tissue, adding complete culture medium of adipose mesenchymal stem cells, inoculating in cell culture dish, and placing in CO at 37 deg.C2Culturing in an incubator, changing the culture solution for the first time after 48 hours, culturing for 4-7 days, then changing a new complete culture medium, culturing for 2-3 days again, discarding the culture solution when 80-90% fusion is achieved, washing the cells for three times by using a phosphate buffer solution, then adding a serum-free culture solution, continuously culturing for 48 hours, and carrying out subculture to obtain the mesenchymal stem cells cultured by the serum-free culture medium.
Preferably, the pH value of the phosphate buffer is 7.0-7.2.
Preferably, the density of the mesenchymal stem cells plated in the culture container is more than 1.8 x 104/cm2
Preferably, the pretreatment using fibronectin is carried out at 37 ℃ for 1 hour.
Preferably, the fibronectin is iMatrix-511 fibronectin.
An anti-saccharification facial mask containing mesenchymal stem cell culture supernatant is characterized in that the facial mask liquid comprises: consists of 0.1 to 5 percent of mesenchymal stem cell culture supernatant and 95 to 99.9 percent of base solution by mass ratio.
Preferably, the base solution comprises a component A, a component B and a component C:
the component A comprises 1-10% of glycerol, 1-4% of butanediol, 1-5% of 1, 2-pentanediol, 0.1-5% of dipropylene glycol, 0.5-5% of diglycerol, 0.5-4% of cane sugar, 0.5-3% of PCA sodium, 0.01-1% of PEG-60 hydrogenated castor oil, 0.1-0.3% of xanthan gum and the balance of water in percentage by mass;
the component B comprises 0.1-0.5% of citric acid, 0.1-0.5% of sodium citrate and the balance of water in percentage by mass;
the component C comprises 0.1-0.5% of phenoxyethanol, 0.1-1% of betaine, 0.1-1% of hydroxyethyl cellulose, 0.0001-1% of carnosine, 0.0001-0.1% of lipoic acid, 0.0001-1% of resveratrol, 0.001-1% of grape seed extract, 0.001-1% of wild soybean extract, 0.001-1% of centella asiatica extract, 0.01-1% of hydrolyzed silk, 0.0001-1% of oligopeptide-5, 0.001-1% of hydrolyzed yeast extract, 0.001-0.3% of daily essence and the balance of water in percentage by mass.
Compared with the prior art, the invention has the beneficial effects that:
1. the facial mask provided by the invention comprises a mesenchymal stem cell culture supernatant and a base solution for promoting and maintaining biological activity. Through reasonable preparation process and formula, the components in the mask liquid interact, coordinate and synergize, good moisturizing effect is realized, skin color is improved, fine lines can be obviously reduced, the skin is fine and smooth, and the skin inflammation is improved. The active substances with various growth factors are produced by utilizing the culture supernatant of the mesenchymal stem cells, and the mask which has the effects of increasing skin elasticity, moisturizing, locking water, resisting inflammation and brightening the skin, is safe and has no toxic or side effect and the preparation method are provided by a special formula.
2. The invention combines the mesenchymal stem cell culture supernatant with the anti-glycation functional components, obtains better skin improvement effect than the anti-glycation functional components such as the mesenchymal stem cell culture supernatant or resveratrol, carnosine, lipoic acid and the like, brightens skin color, improves skin barrier function, locks water and preserves moisture, improves wrinkles, skin textures and the like, and solves the skin problem from the internal cell level.
3. The invention improves the existing method for culturing and collecting the stem cell culture solution, and improves the original method for culturing the stem cell by using the stem cell complete cell growth solution until 80-90% of cells are fused, abandoning the culture solution, washing the cells three times by using a phosphate buffer solution, then adding a serum-free culture solution for continuous culture for 72 hours, and collecting the serum-free culture solution into the method for acclimatizing the cells into the cells which normally grow under the serum-free culture medium, and under the condition of certain number of plates, continuously collecting the culture supernatant of the stem cells after the solution is changed for the second day of subculture, wherein the culture supernatant has good proliferation effect on adult dermal fibroblasts without influencing the activity of the adult dermal fibroblasts. In the process of culturing the mesenchymal stem cells, culture bottles pretreated by the adhesive protein are used for culturing, so that 1:7-1:10 times of cell amplification can be realized, and the requirement of large-scale stable production can be met.
Drawings
FIG. 1 is a graph showing the effect of continuously collecting culture supernatant of human adipose mesenchymal stem cells on proliferation of human dermal fibroblasts (HDF-a) according to the present invention;
FIG. 2 is a graph of skin moisture results according to the present invention;
FIG. 3 is a graph showing the results of the transepidermal water loss rate of the present invention;
FIG. 4 is a graph showing the results of skin wrinkles in accordance with the present invention;
FIG. 5 is a graph of skin complexion results of the present invention;
FIG. 6 is a process flow diagram.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1
Referring to fig. 1-6, the present invention provides a technical solution: a preparation method of an anti-saccharification mask containing mesenchymal stem cell culture supernatant comprises the following steps:
(1) preparing a mesenchymal stem cell culture supernatant: preparing a mesenchymal stem cell culture supernatant: pretreating a cell culture container by using fibronectin, wherein the cell culture container can adopt a cell culture dish, a cell culture bottle and other containers, sucking away the fibronectin after pretreatment, then paving the domesticated P1-generation mesenchymal stem cells in the culture container, changing the liquid on the next day, collecting culture supernatant on the third day, and filtering the culture supernatant with a 0.22-micron filter membrane for later use;
(2) preparing a base solution: heating a component A high-speed mixer comprising 8% of glycerol, 2% of butanediol, 1% of 1, 2-pentanediol, 0.2% of dipropylene glycol, 0.5% of diglycerol, 1% of sucrose, 0.2% of sodium PCA, 0.2% of PEG-60 hydrogenated castor oil, 0.2% of xanthan gum and the balance of water to 80 ℃ for high-speed mixing and stirring, adding a component B comprising 0.2% of citric acid, 0.2% of sodium citrate and the balance of water by mass when the high-speed mixer is cooled to 35 ℃ for high-speed mixing and stirring, then adding C components comprising 0.5% of phenoxyethanol, 0.3% of betaine, 0.15% of hydroxyethyl cellulose, 0.025% of carnosine, 0.03% of lipoic acid, 0.0005% of resveratrol, 0.2% of grape seed extract, 0.15% of wild soybean extract, 0.01% of centella asiatica extract, 0.25% of hydrolyzed silk, 0.01% of oligopeptide-5, 0.015% of hydrolyzed yeast extract, 0.14% of daily essence and the balance of water by mass ratio, and carrying out high-speed mixing and stirring;
(3) and (3) after the high-speed mixer is cooled to room temperature, adding the mesenchymal stem cell culture supernatant in the step (1) into the base solution in the step (2), and carrying out high-speed mixing and stirring.
Specifically, the domestication method of the mesenchymal stem cells is culture in a serum-free culture medium.
Specifically, the tissue containing the mesenchymal stem cells is derived from fat of a healthy person.
Specifically, the extraction method of the mesenchymal stem cells comprises washing blood cells with phosphate buffer solution, and cutting into pieces of about 1mm3Adding 2mL of 1mg/mL collagenase I digestive juice into the fine tissue blocks, transferring the mixture into a 15mL centrifuge tube, carrying out shaking digestion on a constant temperature shaking table at 37 ℃ for 30min, and adding the equal volume mesenchymal stem cell complete culture medium after no large tissue blocks existFinal (a Chinese character of 'gan')Stopping digestion, centrifuging at 1000rpm for 8min to settle cells, removing supernatant and suspended adipose tissue, adding complete culture medium of adipose-derived mesenchymal stem cells, inoculating into cell culture dish, and placing in CO at 37 deg.C2Culturing in an incubator, firstly changing the culture solution after 48 hours, after culturing for 4 days, changing a new complete culture medium, culturing for 2 days again, discarding the culture solution when 80% fusion is achieved, firstly washing the cells for three times by using a phosphate buffer solution, then adding a serum-free culture solution, continuously culturing for 48 hours, and carrying out subculture to obtain the mesenchymal stem cells cultured by the serum-free culture medium.
Specifically, the pH value of the phosphate buffer solution is 7.0.
Specifically, the density of the mesenchymal stem cells plated in the culture container is more than 1.9 multiplied by 104/cm2
Specifically, the pretreatment using fibronectin was carried out at 37 ℃ for 1 hour.
Specifically, the fibronectin is iMatrix-511 fibronectin.
An anti-glycation mask containing mesenchymal stem cell culture supernatant, which comprises: consists of 0.1 percent of mesenchymal stem cell culture supernatant and 99.9 percent of base solution by mass ratio.
Specifically, the base solution comprises a component A, a component B and a component C:
the component A comprises 8% of glycerol, 2% of butanediol, 1% of 1, 2-pentanediol, 0.2% of dipropylene glycol, 0.5% of diglycerol, 1% of cane sugar, 0.2% of PCA sodium, 0.2% of PEG-60 hydrogenated castor oil, 0.2% of xanthan gum and the balance of water in percentage by mass;
the component B comprises 0.2 percent of citric acid, 0.2 percent of sodium citrate and the balance of water in percentage by mass;
the component C comprises 0.5% of phenoxyethanol, 0.3% of betaine, 0.15% of hydroxyethyl cellulose, 0.025% of carnosine, 0.03% of lipoic acid, 0.0005% of resveratrol, 0.2% of grape seed extract, 0.15% of wild soybean extract, 0.01% of centella asiatica extract, 0.25% of hydrolyzed silk, 0.01% of oligopeptide-5, 0.015% of hydrolyzed yeast extract, 0.14% of daily essence and the balance of water in percentage by mass.
Example 2
A preparation method of an anti-saccharification mask containing mesenchymal stem cell culture supernatant comprises the following steps:
(1) preparing a mesenchymal stem cell culture supernatant: pretreating a cell culture container by using fibronectin, sucking away the fibronectin after pretreatment, then paving the domesticated P15 generation mesenchymal stem cells in the culture container, changing the liquid on the next day, collecting culture supernatant on the third day, and filtering the culture supernatant by using a 0.22 mu m filter membrane for later use;
(2) preparing a base solution: heating a component A high-speed mixer comprising 10% of glycerol, 2% of butanediol, 1% of 1, 2-pentanediol, 0.2% of dipropylene glycol, 0.5% of diglycerol, 1% of sucrose, 0.5% of sodium PCA, 0.2% of PEG-60 hydrogenated castor oil, 0.2% of xanthan gum and the balance of water to 80 ℃ for high-speed mixing and stirring, adding a component B comprising 0.1% of citric acid, 0.1% of sodium citrate and the balance of water by mass when the high-speed mixer is cooled to 35 ℃ for high-speed mixing and stirring, then adding C components comprising 0.5% of phenoxyethanol, 0.3% of betaine, 0.15% of hydroxyethyl cellulose, 0.05% of carnosine, 0.03% of lipoic acid, 0.0005% of resveratrol, 0.25% of grape seed extract, 0.15% of wild soybean extract, 0.01% of centella asiatica extract, 0.25% of hydrolyzed silk, 0.01% of oligopeptide-5, 0.015% of hydrolyzed yeast extract, 0.14% of daily essence and the balance of water by mass ratio, and carrying out high-speed mixing and stirring;
(3) and (3) after the high-speed mixer is cooled to room temperature, adding the mesenchymal stem cell culture supernatant in the step (1) into the base solution in the step (2), and carrying out high-speed mixing and stirring.
Specifically, the domestication method of the mesenchymal stem cells is culture in a serum-free culture medium.
Specifically, the tissue containing the mesenchymal stem cells is derived from the umbilical cord of a healthy person.
Specifically, the extraction method of the mesenchymal stem cells comprises washing blood cells with phosphate buffer solution, and cutting into pieces of about 1mm3Adding 2mL of 1mg/mL collagenase I digestive juice into the fine tissue blocks, transferring the mixture into a 15mL centrifuge tube, carrying out shaking digestion on a constant temperature shaking table at 37 ℃ for 30min, and adding the equal volume mesenchymal stem cell complete culture medium after no large tissue blocks existFinal (a Chinese character of 'gan')Stopping digestion, centrifuging at 1000rpm for 8min to settle cells, removing supernatant and suspended adipose tissue, adding complete culture medium of adipose-derived mesenchymal stem cells, inoculating into cell culture dish, and placing in CO at 37 deg.C2Culturing in an incubator, firstly changing the culture solution after 48 hours, after culturing for 5 days, changing a new complete culture medium, culturing for 3 days again, when the fusion reaches 85%, discarding the culture solution, washing the cells for three times by using a phosphate buffer solution, then adding a serum-free culture solution, continuously culturing for 48 hours, and carrying out subculture to obtain the mesenchymal stem cells which can be cultured by the serum-free culture medium.
Specifically, the pH value of the phosphate buffer solution is 7.1.
Specifically, the density of the mesenchymal stem cells plated in the culture container is 3.6 multiplied by 104/cm2
Specifically, the pretreatment using fibronectin was carried out at 37 ℃ for 1 hour.
Specifically, the fibronectin is iMatrix-511 fibronectin.
An anti-glycation mask containing mesenchymal stem cell culture supernatant, which comprises: consists of 0.25 percent of mesenchymal stem cell culture supernatant and 99.75 percent of base solution by mass ratio.
Specifically, the base solution comprises a component A, a component B and a component C:
the component A comprises 10% of glycerol, 2% of butanediol, 1% of 1, 2-pentanediol, 0.2% of dipropylene glycol, 0.5% of diglycerol, 1% of sucrose, 2% of PCA sodium, 0.2% of PEG-60 hydrogenated castor oil, 0.2% of xanthan gum and the balance of water in percentage by mass;
the component B comprises 0.1 percent of citric acid, 0.1 percent of sodium citrate and the balance of water in percentage by mass;
the component C comprises 0.5% of phenoxyethanol, 0.3% of betaine, 0.15% of hydroxyethyl cellulose, 0.05% of carnosine, 0.03% of lipoic acid, 0.0005% of resveratrol, 0.25% of grape seed extract, 0.15% of wild soybean extract, 0.01% of centella asiatica extract, 0.25% of hydrolyzed silk, 0.01% of oligopeptide-5, 0.015% of hydrolyzed yeast extract, 0.14% of daily essence and the balance of water in percentage by mass.
Example 3
A preparation method of an anti-saccharification mask containing mesenchymal stem cell culture supernatant comprises the following steps:
(1) preparing a mesenchymal stem cell culture supernatant: pretreating a cell culture container by using fibronectin, sucking away the fibronectin after pretreatment, then paving the domesticated P30 generation mesenchymal stem cells in the culture container, changing the liquid on the next day, collecting culture supernatant on the third day, and filtering the culture supernatant by using a 0.22 mu m filter membrane for later use;
(2) preparing a base solution: heating a component A high-speed mixer comprising 5% of glycerol, 4% of butanediol, 5% of 1, 2-pentanediol, 5% of dipropylene glycol, 5% of diglycerol, 4% of sucrose, 3% of sodium PCA, 1% of PEG-60 hydrogenated castor oil, 0.3% of xanthan gum and the balance of water to 80 ℃ for high-speed mixing and stirring, adding a component B comprising 0.5% of citric acid, 0.5% of sodium citrate and the balance of water by mass when the high-speed mixer is cooled to 35 ℃ for high-speed mixing and stirring, then adding C components comprising 0.25% of phenoxyethanol, 1% of betaine, 1% of hydroxyethyl cellulose, 1% of carnosine, 0.1% of lipoic acid, 1% of resveratrol, 1% of grape seed extract, 1% of wild soybean extract, 1% of centella asiatica extract, 1% of hydrolyzed silk, 1% of oligopeptide-5, 1% of hydrolyzed yeast extract, 0.3% of daily essence and the balance of water by mass ratio, and mixing and stirring at a high speed;
(3) and (3) after the high-speed mixer is cooled to room temperature, adding the mesenchymal stem cell culture supernatant in the step (1) into the base solution in the step (2), and carrying out high-speed mixing and stirring.
Specifically, the domestication method of the mesenchymal stem cells is culture in a serum-free culture medium.
Specifically, the tissue containing the mesenchymal stem cells is derived from the placenta of a healthy person.
Specifically, the extraction method of the mesenchymal stem cells comprises washing blood cells with phosphate buffer solution, and cutting into pieces of about 1mm3Adding 2mL of 1mg/mL collagenase I digestive juice into the fine tissue blocks, transferring the mixture into a 15mL centrifuge tube, carrying out shaking digestion on a constant temperature shaking table at 37 ℃ for 30min, and adding the equal volume mesenchymal stem cell complete culture medium after no large tissue blocks existFinal (a Chinese character of 'gan')Stopping digestion, centrifuging at 1000rpm for 8min to settle cells, removing supernatant and suspended adipose tissue, adding complete culture medium of adipose-derived mesenchymal stem cells, inoculating into cell culture dish, and placing in CO at 37 deg.C2Culturing in incubator, changing culture medium for the first time after 48 hr, culturing for 7 days, changing new complete culture medium, culturing for 3 days, discarding culture medium when 90% fusion is achieved, washing cells with phosphate buffer solution for three times, adding serum-free culture medium, culturing for 48 hr, and subculturing to obtain the final productCultured mesenchymal stem cells.
Specifically, the pH value of the phosphate buffer solution is 7.2.
Specifically, the density of the mesenchymal stem cells plated in the culture container is more than 2.1 x 104/cm2
Specifically, the pretreatment using fibronectin was carried out at 37 ℃ for 1 hour.
An anti-saccharification facial mask containing mesenchymal stem cell culture supernatant is characterized in that the facial mask liquid comprises: the culture medium consists of 5% of mesenchymal stem cell culture supernatant and 95% of base solution by mass ratio.
Specifically, the base solution comprises a component A, a component B and a component C:
the component A comprises 5% of glycerol, 4% of butanediol, 5% of 1, 2-pentanediol, 5% of dipropylene glycol, 5% of diglycerol, 4% of sucrose, 3% of PCA sodium, 1% of PEG-60 hydrogenated castor oil, 0.3% of xanthan gum and the balance of water in percentage by mass;
the component B comprises 0.5 percent of citric acid, 0.5 percent of sodium citrate and the balance of water in percentage by mass;
the component C comprises 0.25% of phenoxyethanol, 1% of betaine, 1% of hydroxyethyl cellulose, 1% of carnosine, 0.1% of lipoic acid, 1% of resveratrol, 1% of grape seed extract, 1% of wild soybean extract, 1% of centella asiatica extract, 1% of hydrolyzed silk, 1% of oligopeptide-5, 1% of hydrolyzed yeast extract, 0.3% of daily essence and the balance of water in percentage by mass.
And (3) effect testing:
1. and evaluating the water replenishing, moisturizing and locking effects.
1.1 test population: gender and age were randomized, 24 in total, into 3 groups of 8 people each, each group tested one mask each.
1.2 test period: and 28 days.
1.3 test samples: example 1, comparative example 1 (facial mask consisting of base solution of example one without mesenchymal stem cell culture supernatant), and comparative example 2 (facial mask without resveratrol, carnosine and lipoic acid anti-glycation component), all samples were stored at low temperature of 4-8 ℃.
1.4 test conditions: the test environment is a constant temperature and humidity test room, the indoor temperature is kept at 20-22 ℃, and the humidity is kept at 40-60%.
1.5 test instruments: skin tester MP 580 (CK, Germany) and skin moisture test probe Corneometer CM 825 (CK, Germany), skin transepidermal moisture loss rate test probe Tewameter TM300 (CK, Germany).
1.6 test methods: the subjects did not use a functional analogue skin care and cosmetic on the face during and within one month before the test, and the testers used a test mask every night during the test period, which had to be kept cold in a home refrigerator (4-8 ℃). Before each test, the test subjects clean their faces with facial cleanser and makeup remover, sit still in the test room for 30 minutes until the skin is in accordance with the environment. The moisture content of the skin surface of the subject was measured using Corneometer CM 825 at the forehead and left and right cheeks, 3 measurements per area being averaged. The test for transepidermal water loss rate was performed on the skin surface of the subject using a Tewameter TM300, the test areas being the forehead and the left and right cheeks, and the average was taken 3 times. The test period is the first week, the second week and the fourth week before and after the mask is used. Comparing the results of the skin moisture and the trans-epidermal water loss rate (TEWL), wherein the increase of the skin moisture value represents that the skin moisturizing effect is good, and the smaller the TEWL value is, the less the moisture loss is, the better the skin barrier function is, and the stronger the water locking capacity is; conversely, the skin barrier function is impaired, the weaker the water-holding capacity.
1.7 test results: the test results are shown in fig. 2 and 3. According to the detection result, the skin moisture of the testee is obviously improved after the product of the example 1 is used, and the transepidermal water loss rate of the skin of the testee is obviously reduced after the product is used for 28 days, which means that the mask disclosed by the invention has good water replenishing, moisturizing and water locking effects, has the functions of repairing the skin barrier and preventing the skin epidermal water from being lost. Compared with the results of the comparative example 1 and the comparative example 2, the facial mask added with the mesenchymal stem cell culture supernatant component and the three anti-saccharification components of resveratrol, carnosine and lipoic acid has better moisturizing and skin barrier repair effects.
2. Evaluation of anti-wrinkle efficacy
2.1 test population: gender and age were randomized, 24 in total, into 3 groups of 8 people each, each group tested one mask each.
2.2 test period: 28 days
2.3 test samples: example 1, comparative example 1 (facial mask consisting of base solution of example one without mesenchymal stem cell culture supernatant), and comparative example 2 (facial mask without resveratrol, carnosine and lipoic acid anti-glycation component), all samples were stored at low temperature of 4-8 ℃.
2.4 test conditions: the test environment is a constant temperature and humidity test room, the indoor temperature is kept at 20-22 ℃, and the humidity is kept at 40-60%.
2.5 test instruments: VISIA seventh generation skin monitor (Canfield, USA).
2.6 test methods: the subjects did not use a functional analogue skin care and cosmetic on the face during and within one month before the test, and the testers used a test mask every night during the test period, which had to be kept cold in a home refrigerator (4-8 ℃). Before each test, the test subjects clean their faces with facial cleanser and makeup remover, sit still in the test room for 30 minutes until the skin is in accordance with the environment. VISIA was used to photograph the front, left, and right sides of the face of the subject, and the wrinkle detection data was analyzed by VISIA, and 3 times of data were averaged. The results compare, the lower the absolute number of skin wrinkles, representing a lower number of skin wrinkles.
2.7 test results: the test results are shown in fig. 4. As can be seen from the test results, the skin wrinkles of the subjects were significantly improved after the products of example 1 were used, and wrinkles of the corners of the eyes of the subjects were significantly reduced after 28 days of use, indicating that the anti-glycation mask of the present invention has anti-wrinkle and repairing effects. Compared with the results of the comparative example 1 and the comparative example 2, the mesenchymal stem cell culture supernatant component has better anti-wrinkle and repairing effects when being matched with resveratrol, carnosine and lipoic acid anti-saccharification components.
3. Skin complexion efficacy evaluation:
3.1 test population: gender and age were randomized, 24 in total, into 3 groups of 8 people each, each group tested one mask each.
3.2 test period: 28 days
3.3 test samples: example 1, comparative example 1 (facial mask consisting of base solution of example one without mesenchymal stem cell culture supernatant), and comparative example 2 (facial mask without resveratrol, carnosine and lipoic acid anti-glycation component), all samples were stored at low temperature of 4-8 ℃.
3.4 test conditions: the test environment is a constant temperature and humidity test room, the indoor temperature is kept at 20-22 ℃, and the humidity is kept at 40-60%.
3.5 test instruments: skin tester MP 580 (CK, germany) and skin color test probe colorimeter cl400 (CK, germany).
3.6 test methods: the subjects did not use a functional analogue skin care and cosmetic on the face during and within one month before the test, and the testers used a test mask every night during the test period, which had to be kept cold in a home refrigerator (4-8 ℃). Before each test, the test subjects clean their faces with facial cleanser and makeup remover, sit still in the test room for 30 minutes until the skin is in accordance with the environment. Subjects were tested for skin complexion using a Colorimeter CL400, with the test areas being the forehead and the left and right cheeks, and 3 measurements were averaged for each test area. The test period is the first week, the second week and the fourth week before and after the mask is used. The skin complexion results were compared to the mask before use, with an increase in the complexion value indicating a whitening of the skin.
3.7 test results: the test results are shown in fig. 5. According to the detection results, the skin complexion of the testee is obviously improved after the product of the example 1 is used, the skin complexion of the testee is obviously improved after the product is used for 28 days, and the anti-saccharification mask has the effect of improving the skin complexion. Compared with the results of comparative example 1 and comparative example 2, it can be seen that the mesenchymal stem cell culture supernatant component has a better skin color improvement effect when being combined with resveratrol, carnosine and lipoic acid anti-glycation components.
Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that changes, modifications, substitutions and alterations can be made in these embodiments without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.

Claims (10)

1. A preparation method of an anti-saccharification mask containing mesenchymal stem cell culture supernatant is characterized by comprising the following steps:
(1) preparing a mesenchymal stem cell culture supernatant: pretreating a cell culture container by using fibronectin, sucking away the fibronectin after pretreatment, then paving the domesticated P1-P30 generation mesenchymal stem cells in the culture container, changing the liquid on the next day, collecting culture supernatant on the third day, and filtering the culture supernatant with a 0.22 mu m filter membrane for later use;
(2) preparing a base solution: heating the A component comprising 1-10% of glycerol, 1-4% of butanediol, 1-5% of 1, 2-pentanediol, 0.1-5% of dipropylene glycol, 0.5-5% of diglycerol, 0.5-4% of sucrose, 0.5-3% of sodium PCA, 0.01-1% of PEG-60 hydrogenated castor oil, 0.1-0.3% of xanthan gum and the balance of water to 80-85 ℃ by a high-speed mixer, carrying out high-speed mixing stirring, adding the B component comprising 0.1-0.5% of citric acid, 0.1-0.5% of sodium citrate and the balance of water when the temperature of the high-speed mixer is cooled to below 40 ℃, carrying out high-speed mixing stirring, and then adding the B component comprising 0.1-0.5% of phenoxyethanol, 0.1-1% of betaine, 0.1-1% of hydroxyethyl cellulose, 0.0001-1% of carnosine, 0.lipoic acid-0.1% of, 0.0001-1% of resveratrol, 0.001-1% of grape seed extract, 0.001-1% of wild soybean extract, 0.001-1% of centella asiatica extract, 0.01-1% of hydrolyzed silk, 0.0001-1% of oligopeptide-5, 0.001-1% of hydrolyzed yeast extract, 0.001-0.3% of daily essence and the balance of water;
(3) and (3) after the high-speed mixer is cooled to room temperature, adding the mesenchymal stem cell culture supernatant in the step (1) into the base solution in the step (2), and carrying out high-speed mixing and stirring.
2. The method for preparing an anti-glycation mask containing mesenchymal stem cell culture supernatant according to claim 1, wherein the method comprises the following steps: the domestication method of the mesenchymal stem cells is culture in a serum-free culture medium.
3. The method for preparing an anti-glycation mask containing mesenchymal stem cell culture supernatant according to claim 1, wherein the method comprises the following steps: the tissue containing mesenchymal stem cells is derived from umbilical cord, placenta, fat, bone marrow or dental pulp of a healthy subject.
4. The method for preparing an anti-glycation mask containing mesenchymal stem cell culture supernatant according to claim 1, wherein the method comprises the following steps: the extraction method of the mesenchymal stem cells comprises washing blood cells with phosphate buffer solution, and cutting into pieces of about 1mm3Adding 2mL of 1mg/mL collagenase I digestive juice into the fine tissue blocks, transferring the mixture into a 15mL centrifuge tube, carrying out shaking digestion on a constant temperature shaking table at 37 ℃ for 30min, and adding the equal volume mesenchymal stem cell complete culture medium after no large tissue blocks existFinal (a Chinese character of 'gan')Stopping digestion, centrifuging at 1000rpm for 8min to settle cells, removing supernatant and suspended adipose tissue, adding complete culture medium of adipose-derived mesenchymal stem cells, inoculating into cell culture dish, and placing in CO at 37 deg.C2Culturing in an incubator, changing the culture solution for the first time after 48 hours, culturing for 4-7 days, then changing a new complete culture medium, culturing for 2-3 days again, discarding the culture solution when 80-90% fusion is achieved, washing the cells for three times by using a phosphate buffer solution, then adding a serum-free culture solution, continuously culturing for 48 hours, and carrying out subculture to obtain the mesenchymal stem cells cultured by the serum-free culture medium.
5. The method for preparing an anti-glycation mask containing mesenchymal stem cell culture supernatant according to claim 1, wherein the method comprises the following steps: the pH value of the phosphate buffer solution is 7.0-7.2.
6. Mesenchymal stem-containing composition according to claim 1The preparation method of the anti-saccharification mask of the cell culture supernatant is characterized by comprising the following steps: the density of the mesenchymal stem cells plated in the culture container is more than 1.8 multiplied by 104/cm2
7. The method for preparing an anti-glycation mask containing mesenchymal stem cell culture supernatant according to claim 1, wherein the method comprises the following steps: the pretreatment conditions using fibronectin were 1 hour at 37 ℃.
8. The method for preparing an anti-glycation mask containing mesenchymal stem cell culture supernatant according to claim 1, wherein the method comprises the following steps: the fibronectin is iMatrix-511 fibronectin.
9. An anti-saccharification facial mask containing mesenchymal stem cell culture supernatant is characterized in that the facial mask liquid comprises: consists of 0.1 to 5 percent of mesenchymal stem cell culture supernatant and 95 to 99.9 percent of base solution by mass ratio.
10. The anti-glycation mask containing mesenchymal stem cell culture supernatant according to claim 7, wherein: the base solution comprises a component A, a component B and a component C:
the component A comprises 1-10% of glycerol, 1-4% of butanediol, 1-5% of 1, 2-pentanediol, 0.1-5% of dipropylene glycol, 0.5-5% of diglycerol, 0.5-4% of cane sugar, 0.5-3% of PCA sodium, 0.01-1% of PEG-60 hydrogenated castor oil, 0.1-0.3% of xanthan gum and the balance of water in percentage by mass;
the component B comprises 0.1-0.5% of citric acid, 0.1-0.5% of sodium citrate and the balance of water in percentage by mass;
the component C comprises 0.1-0.5% of phenoxyethanol, 0.1-1% of betaine, 0.1-1% of hydroxyethyl cellulose, 0.0001-1% of carnosine, 0.0001-0.1% of lipoic acid, 0.0001-1% of resveratrol, 0.001-1% of grape seed extract, 0.001-1% of wild soybean extract, 0.001-1% of centella asiatica extract, 0.01-1% of hydrolyzed silk, 0.0001-1% of oligopeptide-5, 0.001-1% of hydrolyzed yeast extract, 0.001-0.3% of daily essence and the balance of water in percentage by mass.
CN201911342835.4A 2019-12-24 2019-12-24 Anti-saccharification mask containing mesenchymal stem cell culture supernatant and preparation method thereof Pending CN110934815A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201911342835.4A CN110934815A (en) 2019-12-24 2019-12-24 Anti-saccharification mask containing mesenchymal stem cell culture supernatant and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911342835.4A CN110934815A (en) 2019-12-24 2019-12-24 Anti-saccharification mask containing mesenchymal stem cell culture supernatant and preparation method thereof

Publications (1)

Publication Number Publication Date
CN110934815A true CN110934815A (en) 2020-03-31

Family

ID=69912414

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911342835.4A Pending CN110934815A (en) 2019-12-24 2019-12-24 Anti-saccharification mask containing mesenchymal stem cell culture supernatant and preparation method thereof

Country Status (1)

Country Link
CN (1) CN110934815A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114262684A (en) * 2021-12-07 2022-04-01 上海泽充生物技术有限公司 Method for extracting supernatant of stem cells

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120064182A1 (en) * 2009-01-30 2012-03-15 Beiersdorf Ag Cosmetic or dermatological preparation comprising collagen, chitosan, glycosylaminoglycan and cell growth promoting peptide and/or cellular complex
CN107854418A (en) * 2017-11-10 2018-03-30 南京九圣生物科技股份有限公司 A kind of human umbilical cord mesenchymal stem cells excretion external use creams and preparation method thereof
CN108624555A (en) * 2018-05-16 2018-10-09 浙江因兆艾生物科技有限公司 The preparation method of stem cell natural secretion polypeptide active additive, facial mask liquid of complex polypeptide and preparation method thereof
CN109718195A (en) * 2019-03-15 2019-05-07 上海市东方医院(同济大学附属东方医院) Facial mask liquid containing stem cell factor
CN110269833A (en) * 2019-06-05 2019-09-24 湖南丰晖生物科技有限公司 A kind of umbilical cord mesenchymal stem cells preparation and its preparation method and application
CN110478306A (en) * 2019-09-05 2019-11-22 广东唯泰生物科技有限公司 Facial mask of the culture supernatant containing placenta mesenchyma stem cell and preparation method thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120064182A1 (en) * 2009-01-30 2012-03-15 Beiersdorf Ag Cosmetic or dermatological preparation comprising collagen, chitosan, glycosylaminoglycan and cell growth promoting peptide and/or cellular complex
CN107854418A (en) * 2017-11-10 2018-03-30 南京九圣生物科技股份有限公司 A kind of human umbilical cord mesenchymal stem cells excretion external use creams and preparation method thereof
CN108624555A (en) * 2018-05-16 2018-10-09 浙江因兆艾生物科技有限公司 The preparation method of stem cell natural secretion polypeptide active additive, facial mask liquid of complex polypeptide and preparation method thereof
CN109718195A (en) * 2019-03-15 2019-05-07 上海市东方医院(同济大学附属东方医院) Facial mask liquid containing stem cell factor
CN110269833A (en) * 2019-06-05 2019-09-24 湖南丰晖生物科技有限公司 A kind of umbilical cord mesenchymal stem cells preparation and its preparation method and application
CN110478306A (en) * 2019-09-05 2019-11-22 广东唯泰生物科技有限公司 Facial mask of the culture supernatant containing placenta mesenchyma stem cell and preparation method thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
侯宗柳: "《围产期成体干细胞基础与临床应用》", 31 October 2016, 云南科技出版社 *
国家药品监督管理局: "反重力肌透面膜", 《国产非特殊化妆品备案服务平台》 *
成秋桂 等: "抗氧化在化妆品行业的应用进展", 《日用化学品科学》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114262684A (en) * 2021-12-07 2022-04-01 上海泽充生物技术有限公司 Method for extracting supernatant of stem cells

Similar Documents

Publication Publication Date Title
CN105168085B (en) Mescenchymal stem cell derives liquid and preparation method thereof and the application in cosmetics
CN110129265A (en) A kind of umbilical cord mesenchymal stem cells excretion body, preparation method and the application in cosmetics
CN103179875A (en) Cosmetic bio-cellulose mask pack sheet and method for manufacturing same
CN112494403B (en) Oat fermentation liquor and preparation method and application thereof
CN103908424A (en) Beautifying and nursing essence and preparation method thereof
CN111821252A (en) Anti-wrinkle essence containing adipose-derived stem cell extract and preparation method thereof
CN110115704B (en) Enzyme composition and application thereof in cosmetics with whitening function
CN110151678A (en) It is a kind of for improving the composition and cosmetics comprising source of human stem cell excretion body of wrinkle
CN109394639A (en) A kind of anti-ageing activating essence and preparation method thereof containing ferment
CN114344188A (en) Hair loss prevention and hair growth promoting composition and preparation method thereof
CN109125246A (en) The anti-ageing composition of skin
CN109223677A (en) A kind of Semen Coicis hydrolysate, preparation method and its application in cosmetics
KR101224519B1 (en) Cosmetic composition containing phellinus linteus mycelium ferment collagen filtrate for preventing skin aging and improving skin wrinkle
CN111150701A (en) Anti-wrinkle firming essence and preparation method thereof
CN107260653A (en) A kind of cosmetic composition and its preparation method and application
CN110934815A (en) Anti-saccharification mask containing mesenchymal stem cell culture supernatant and preparation method thereof
CN109200011A (en) A kind of skin care item and preparation method thereof
CN110522709A (en) Skin care compositions and methods and application thereof
KR102350857B1 (en) Cosmetic composition containing lactic acid bacteria fermentation of chrysanthemum and magnolia extracted with YU SEONG hot spring water
CN111265454B (en) Moisture-preserving and water-replenishing anti-aging cosmetic composition
CN107375189A (en) A kind of stem cell composition and face rejuvenation cosmetic formulation
KR20130114808A (en) Cosmetics composition including collagen natural fermented broth
KR101521268B1 (en) Manufacturing method of fermented composition of amniotic fluid of Sturgeon, fermented composition of amniotic fluid of Sturgeon obtained therefrom and cosmetic composition comprising the same
CN110151677A (en) Mescenchymal stem cell extract, extracting method and the application in terms of skin-tightening and anti-aging of gene modification
CN108653182B (en) Preparation method and application of active ingredient extracting solution of bovine umbilical cord

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20200331

RJ01 Rejection of invention patent application after publication